These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6317326)

  • 1. Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
    LeBel M; Paone RP; Lewis GP
    Drug Intell Clin Pharm; 1983 Dec; 17(12):908-10. PubMed ID: 6317326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of selected second- and third-generation cephalosporins with creatinine determination.
    Guay DR; Meatherall RC; Macaulay PA
    Am J Hosp Pharm; 1983 Mar; 40(3):435-8. PubMed ID: 6846351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC
    Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ten new beta-lactam antibiotics on urine glucose test methods.
    LeBel M; Paone RP; Lewis GP
    Drug Intell Clin Pharm; 1984; 18(7-8):617-20. PubMed ID: 6745089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
    Appelbaum PC; Tamim J; Pankuch GA; Aber RC
    Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
    Kroll MH; Koch TR; Drusano GL; Warren JW
    Am J Clin Pathol; 1984 Aug; 82(2):214-6. PubMed ID: 6087652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
    Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of ceftriaxone, cefoperazone, and ceftizoxime.
    Hamilton RA; Kowalsky SF; McCormick EM; Echols RM
    Clin Pharm; 1987 Jul; 6(7):567-9. PubMed ID: 3480089
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzer.
    Polk RE; Stephens GH
    Am J Hosp Pharm; 1981 Jun; 38(6):866-8. PubMed ID: 6454343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
    Barriere SL; Ozasa DC; Mordenti J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azthreonam activity against gram-negative bacilli.
    Bremner DA
    Chemotherapy; 1984; 30(1):44-8. PubMed ID: 6537908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of ceftazidime (GR 20263) and other beta-lactamase stable cephalosporins against pseudomonas. Effect of inoculum size and divalent cation supplementation.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():345-8. PubMed ID: 19803012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cefoperazone, cefotaxime, ceftazidime and aztreonam on phagocytosis by human neutrophils in vitro.
    Lingaas E; Midtvedt T
    J Antimicrob Chemother; 1989 May; 23(5):701-10. PubMed ID: 2668245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of imipenem on the serum resistance of enterobacteriaceae.
    Wiemer CW; Kubens B; Opferkuch W
    Rev Infect Dis; 1985; 7 Suppl 3():S426-31. PubMed ID: 3863217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ceftizoxime, a new cephalosporin antibiotic, on binding of bilirubin to human serum albumin.
    Sakamoto H; Murakawa T; Hirose T; Nishida M
    Chemotherapy; 1983; 29(4):244-8. PubMed ID: 6307603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
    Elliott TS; Greenwood D
    J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P; Robert J; Le Noc D
    Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.